Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Acute Tinnitus With Migraine Medications
NCT06799169Phase 4Suspended
- Sponsor
- University of California, Irvine
- Start
- Jun 2025
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nortriptyline, topiramate, verapamil and paroxetine in tinnitus (2 arms), sponsored by University of California, Irvine. Primary endpoint: Tinnitus Functional Index at 8 weeks. Started Jun 2025; status: suspended.
02
Drugs
nortriptylinetopiramateverapamilparoxetine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT06799169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799169.